|
Match
|
Document |
Document Title |
|
|
7262326 |
Process for the synthesis of indanylamine or aminotetralin derivatives and novel intermediates
A process for preparing indanylamine and aminotetralin derivatives from indanone or tetralone oximes by acylating the oximes with an organic anhydride, followed by catalytic hydrogenation in the...
|
|
|
7157604 |
Selective estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen...
|
|
|
6737547 |
Compositions containing and methods of using N-acyl-1H-aminoindenes
The present invention provides novel aminoindenes having the structure: wherein n is 1 or 2, R 1 is hydrogen, linear or branched chain C 1 -C 8 alkyl or linear or branched chain C 1 -C 8 ...
|
|
|
6683220 |
Process for the preparation of optically pure or enriched racemic tetralone
A process for producing substantially optically pure sertraline utilizes chromatographic separation on a solid stationary chiral phase of spherical clay particles having an interlayer containing an...
|
|
|
6649796 |
Process for the preparation of acetamide derivatives
The invention provides a process for the preparation of diphenylmethylthioacetamide (I) as described in Scheme 4 comprising reacting of the isothiouronium salt or its corresponding base of the...
|
|
|
6635783 |
Bicyclic 1,3-aminoalcohols, d8-metal complexes and hydrogenation processes
Bicyclic amino alcohols, whose amino group and hydroxy group are bonded in positions 1,3 adjacent to the bridge, for example are valuable ligands for metal complexes of the d-8 metals of the...
|
|
|
6602903 |
Substituted heterocyclic compounds
The invention relates to compounds of formula (I): and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
|
|
|
6313175 |
Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
Novel meta substituted arylalkylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin...
|
|
|
6297399 |
Indane compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity
Indane compounds of general formulas (7) and (8) and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilizing activity and/or anti-inflammatory...
|
|
|
6262308 |
Process for the preparation of racemic sertraline
The invention relates to a process for preparing cis-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-nap
hthylamine, or racemic sertraline, corresponding to formula (I) ##STR1## in salt...
|
|
|
6140372 |
Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
The invention relates to derivatives of general formula I ##STR1## as defined in the description. The invention also relates to a process for their preparation and to their therapeutic use, in...
|
|
|
6028112 |
Spirocyclopropyl fluorenes as melatonergic agents
There is provided novel spirocyclopropyl fluorene derivatives having the general Formula I ##STR1## wherein R, R 1 and X are as defined herein which are useful as melatonergic agents.
|
|
|
5973204 |
Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
The present invention relates to 3-demethyl-thiocolchicine derivatives of general formula (I) ##STR1## in which R can be ##STR2## to a process for the preparation thereof, to pharmaceutical...
|
|
|
5849945 |
Aminotetralone derivatives and preparation process thereof
The present invention pertains to a process for the preparation of Compound (4) through the below-described reaction route: ##STR1## wherein R 1 and R 2 each represents H, halogen, OH or C 1 -6...
|
|
|
5834521 |
Substituted dibenz (A F)azulenes and methods of preparation
Tetracyclic compounds having the following structure are described: ##STR1## wherein R 1 -R 10 are as defined. The tetracyclic compounds are capable of potent effects on steroid sensitive tissues...
|
|
|
5817874 |
Process for alkylating and smiles rearrangement of hydroxy aromatics
The present invention is a process of converting a hydroxy aromatic into a 2-hydroxy-N-arylacetamide, comprising: (1) treating a reaction mixture comprising a salt of a hydroxy aromatic with an...
|
|
|
5646188 |
Polyamine derivatives of 1-aminoindan
A compound of general formula I ##STR1## wherein n is 1 or 2; R 1 and R 2 are each independently hydrogen, hydroxy, substituted or unsubstituted C 1 -4 alkyl, substituted or unsubstituted C 1 -4...
|
|
|
5599985 |
Optically pure 1-amido-2-indanols
A two-step process for the conversion of a trans-1-amino-2-hydroxycycloalkane stereoselectively to a cis-1-amino-2-hydroxycycloalkane is disclosed. The novel step, a one-step hydrolysis with formal...
|
|
|
5530002 |
1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics
Compounds of formula: ##STR1## in which X represents a hydrogen atom, a C 1 -C 3 alkoxy group or a cyclopropylmethoxy group and Y represents a hydrogen atom or a methoxy group, are useful in the...
|
|
|
5463126 |
Process for preparing sertraline
The invention provides the substantially geometrically pure cis-stereoisomeric form of a compound of formula (I) and the substantially geometrically and optically pure cis-stereoisomeric form of a...
|
|
|
5442116 |
Process for preparing sertraline intermediates
The invention provides the substantially geometrically and optically pure trans-stereoisomeric form of a compound of formula (I): ##STR1## wherein R 1 is H or C 1 -C 4 alkyl, together with...
|
|
|
5225595 |
Arylsulfonyl compounds with unsaturated radicals
Sulfonyl compounds of the formula ##STR1## where Ar is the radical of a benzene or naphthalene ring, R 1 and R 2 are each hydrogen, substituted or unsubstituted C 1 -C 4 -alkyl, substituted...
|
|
|
5196454 |
Method of treating disorders of the dopaminergic systems using 2,5-diaminotetralines
The invention relates to novel 2,5-diaminotetralines of the formula: ##STR1## wherein R1, R2, R3 and R4 are defined herein, processes for preparing them and their use in pharmaceutical...
|
|
|
5189065 |
Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an anti-tumor medicament
The use of products of formula (I) is described, wherein X and Y represent hydrogen, hydroxy or alkoxy; and R 1 and R 2 represent H, alkyl, alkenyl or alkynyl, arylalkyl, acyl or R 1 and R 2 ...
|
|
|
5153227 |
Phenylsulfonyl nitromethanes as aldose reductase inhibitors
The invention concerns novel pharmaceutical compositions for use in the treatment of certain complications of diabetes and galactosemia and which contain a nitromethane derivative (or its non-toxic...
|
|
|
5128479 |
Oxidized diphenylheteroalkanes
Oxidized diphenylheteroalkanes of the formula I ##STR1## where R 1 to R 6 and A have the meanings specified in the description, and the preparation thereof are described. The substances are...
|
|
|
5114975 |
Anilinophenyl carbodiimides compositions containing them, and the use thereof in pest control
The invention relates to novel substituted aryloxyphenylthioureas, aryloxyphenylisothioureas and aryloxyphenylcarobodiimides of formula I ##STR1## wherein R 1 is C 1 -C 12 alkyl, unsubstituted...
|
|
|
5071875 |
Substituted 2-amidotetralins as melatonin agonists and antagonists
The present invention relates generally to compounds having melatonin receptor activities and in particular to substituted 2-amidotetralin derivatives; to pharmaceutical preparations comprising...
|
|
|
5026730 |
Anilinophenylthioureas, compositions containing them, and the use thereof in pest control
The invention relates to novel substituted anilinophenylthioureas, anilinophenylisothioureas and anilinophenylcarbodiimides of formula I ##STR1## wherein R 1 is C 1 -C 12 alkyl, unsubstituted or...
|
|
|
5021414 |
Phenol derivatives
A phenol derivative of the formula NU--A--X--R 1 wherein NU is a defined bis-phenolic nucleus including a hydroxyphenyl-hydroxynaphthyl; hydroxyphenyl-hydroxyindanyl,...
|
|
|
4975461 |
P-aminophenols, derivatives thereof and method of use
p-Aminophenols are provided having the structure ##STR1## wherein m is 0, 1 or 2; n is 0, 1, 2 or 3; R 1 and R 2 may be the same or different and are H, hydroxy or alkoxy; R 3 is H, lower alkyl,...
|
|
|
4922016 |
Process for the preparation of N-(sulfonylmethyl) formamide compounds
N-(sulfonylmethyl)formamides are obtained by reacting a sulfinic acid, formaldehyde and formamide in the presence of a second acid and a controlled amount of water. The formamides can be converted...
|
|
|
4889924 |
Bisazo compounds
A bisazo compound having good electrophotographic properties is disclosed, which is represented by formula (I) ##STR1## wherein X represents a hydrogen atom, a chlorine atom or a nitro group. A...
|
|
|
4885314 |
Novel HMG-CoA reductase inhibitors
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors which are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I)...
|
|
|
4792628 |
Indane derivatives and salts thereof
Indane derivatives and their salts represented by the general formula (1), ##STR1## wherein R 1 is an amino group which may have lower alkyl groups as the substituents, a hydroxylimino group, an...
|
|
|
4755511 |
Tricyclic pyridazinone compounds
This invention relates to tricyclic pyridazinone compounds, pharmaceutical compositions containing the compounds, and a method of stimulating cardiac activity in a mammal by administering an...
|
|
|
4754066 |
Age protection agents, the production thereof and the polymers which contain them
Compounds corresponding to the formula ##STR1## wherein R 1 and R 2 represent H or C 1 -C 4 -alkyl, R 3 represents H or CH 3 , R 4 represents C 7 -C 20 -aralkyl, n represents 1 or...
|
|
|
4692463 |
Antiinflammatory 2,3-didemethylcolchicine and additional derivatives
The present invention describes the finding of potent antiinflammatory properties in 2,3-didemethylcolchicine and its analogs.
|
|
|
4692447 |
Tricyclic dihydropyridazinones and pharmaceutical compositions containing them
The tricyclic dihydropyridazinone derivatives having formula I ##STR1## are endowed with interesting hypotensive, vasodilating, antiaggregant, antithrombotic and cytoprotective properties and are...
|
|
|
4642373 |
Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or...
|
|
|
4602032 |
Dibenz[cd,f]indole derivatives, their preparation and pharmaceutical compositions containing them
A 2-alkyl-9,10-dioxy-4,5,5a,6-tetrahydro-dibenz[cd,f]indole or an acid addition salt thereof is a useful anti-parkinson agent.
|
|
|
4540806 |
Benzocycloalkane amines
Benzocycloalkane amine derivatives and their non-toxic acid addition salts as novel analgesic agents.
|
|
|
4473704 |
Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or...
|
|
|
4473586 |
Aminoalkyl dihydronaphthalenes
Disclosed herein are 1-aminoalkyl-3,4-dihydronaphthalenes represented by the formula ##STR1## wherein n is 1 or 2; R, R 1 , and R 2 are independently selected from hydrogen, hydroxy, loweralkoxy...
|
|
|
4442126 |
1,2,3,4-Tetrahydronaphthalene derivatives
New compounds of the formula: ##STR1## wherein R 1 represents a hydrogen atom or an alkanoyl group containing from 1 to 4 carbon atoms, R 2 and R 3 each represent a hydrogen atom or a C 1 -C 4 ...
|
|
|
4435426 |
Ethers of phenol active on the cardiovascular system, process for preparing same and use thereof in drugs
The present invention relates to novel products, responding to general formula: ##STR1## in which R 1 and R 2 taken together represent an atom of oxygen O or R 1 represents hydrogen and R 2 ...
|
|
|
4394314 |
Process of preparing aromatic aldehydes by reacting selected aromatic compounds with formamidine acetate and an organic acid anhydride
A process of reacting a ring carbon atom of an aromatic compound Ar with a compound of the formula H 2 NCHNH 2 + CH 3 CO 2 - , and an anhydride which has the ##STR1## at from 10° to 200° C....
|
|
|
4320148 |
2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha.sub.1 agonist activity
2-Aminotetralin compounds having 5- and 8- substituents are centrally acting alpha 1 agonists.
|
|
|
4310693 |
o-Aminophenol compounds
o-Aminophenol derivatives are described represented by the formula (I) ##STR1## wherein R represents --NH 2 or --NH--CO--R 6 ; R 1 and R 2 which may be the same or different, each can represent...
|
|
|
4299984 |
Benzo-bicyclononene-derivatives
The present invention relates to novel biologically active tricyclic compounds of the general formula: ##STR1## and salts thereof, in which R 1 and R 2 stand for hydrogen, alkyl or alkenyl, an...
|